Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
39.12
-0.96 (-2.40%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Medline Stock Forecast
Stock Price Forecast
According to 26 analysts polled by S&P Global, Medline stock has a consensus rating of "Buy" and an average price target of $50.65. The average 1-year stock price forecast is 29.47% higher than the current stock price, while the lowest is $40 (+2.25%) and the highest is $62 (+58.49%).
Price Target: $50.65 (+29.47%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Medline stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 17 | 17 | 17 | 17 | 16 |
| Buy | 6 | 6 | 6 | 7 | 7 | 6 |
| Hold | 5 | 5 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 28 | 28 | 28 | 28 | 26 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $57 → $50 | Buy | Maintains | $57 → $50 | +27.81% | Jul 29, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 9, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $55 → $48 | Buy | Maintains | $55 → $48 | +22.70% | Jul 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $53 | Buy | Maintains | $53 | +35.48% | Jul 9, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 22, 2026 |
Financial Forecast
Revenue This Year
31.08B
from 28.43B
Increased by 9.33%
Revenue Next Year
35.03B
from 31.08B
Increased by 12.70%
EPS This Year
1.51
from 1.79
Decreased by -15.68%
EPS Next Year
1.67
from 1.51
Increased by 10.09%
EPS and Forward PE are based on non-GAAP adjusted numbers.